Registrations open now
Register Interest →
FDA Listed OTC Medicine Live on Amazon.com 5 Star Reviews NZ Herald Featured 14 SKU Pipeline HSA / FSA Eligible NZ Owned, US Scaling FDA Listed OTC Medicine Live on Amazon.com 5 Star Reviews NZ Herald Featured 14 SKU Pipeline HSA / FSA Eligible NZ Owned, US Scaling
Now Open — Registrations of Interest

Be Part of
the Movement. Take On
Big Pharma.

A New Zealand couple spent 20 years building something the giants refused to. Now with FDA listing, 5-star reviews on Amazon, and a 14-product pipeline, they’re inviting you to own a piece of the fight.

Healthtex Limited — PledgeMe Campaign
NZD $21M
Pre-money valuation
$400K – $2M
Raise target on PledgeMe
USD $30B
Target US OTC market by 2027
Registrations of interestBuilding
Limited spots at pre-launch pricing

David vs Goliath.
This time, David has an Asteroid in his sling

Big pharma has dominated the US self-care market for decades, delivering the same tired formulas with billion-dollar marketing budgets. Two NZ pharmacists decided enough was enough.

Big Pharma
Goliath
  • Steroid-based formulas used for decades, raising safety concerns
  • Retail shelf dominated, low margins, low loyalty
  • Low consideration for customers feelings
  • Treatments in isolation, no lifestyle advice
  • No NZ connection, no real urgency to disrupt
Healthtex — Asteroid™
David
  • Steroid-free formulation, effective and safe for daily use
  • The only FDA-listed topical OTC haemorrhoid medicine with 5-way action and ‘rapid acting’ label claim in US market.
  • Already live on Amazon.com from January 2026 at USD $29.99
  • E-commerce, 14 product pipeline covering analgesics, digestive health, allergy and weight management to follow.
  • Built from New Zealand — and you can own a piece of it
20+
Years of pharmacist-led R&D behind the formulation
14
FDA-listed SKUs ready to go to market after Asteroid
$30B
US OTC self-care market being targeted by end of 2027
5★
Reviews on Amazon.com since January 2026 soft launch
Alice Delee and Tim O'Donoghue, co-founders of Healthtex
Alice Delee & Tim O’Donoghue
Co-founders, Healthtex / Neoqura
20
Years

One couple’s dream. Two decades of graft.

Tim O’Donoghue is a pharmacist, entrepreneur, and former University of London lecturer who spent years listening to what real people actually needed. Alice Delee brings deep expertise in women’s consumer health. Together they built Neoqura and Asteroid™ from the ground up.

This isn’t a startup on a whiteboard. This is a product that is already selling, already FDA-listed, already earning 5 stars on the world’s largest marketplace. They built it so that New Zealanders could share in what comes next.

CEO / Pharmacist
Tim O’Donoghue
Consumer Health
Alice Delee
E-commerce
Richard Conway
Pharmacist/E-Commerce
Michael Guy

Pharmacist-designed.
FDA-listed.
Already winning.

Asteroid™ Ointment is unlike anything else on the US market. 5-way action in one steroid-free formula. Rapid cooling action. Discreet, elegant packaging. Built for a generation that asked for better -and got it!

01
Only of its kindThe only FDA-listed topical OTC medicine for haemorrhoid treatment with a 5-way action and a rapid-acting label claim in the USA
02
Steroid-free, daily-use formula. Trusted ingredients, in a barrier formulation that works.
03
HSA and FSA Health plan eligible.Can be purchased with pre-tax earnings. Sold on Amazon.com from USD $29.99 since January 2026.
04
Platform of 14 products by December 2027. Asteroid is just the first. Analgesics, digestive health, allergy, and weight management are all queued and FDA-listing verified.
Invest in the Platform →
Tim O'Donoghue
Asteroid brand logo
NZ Herald

We’re building a platform of 14 over-the-counter medicines for the US market… all 14 have US FDA listings and are ready to go to market following Asteroid

Tim O’Donoghue — NZ Herald, April 2026

The window is open.
It won’t stay that way.

This is the moment before the story is widely known. Be part of the founding chapter of a New Zealand company taking the fight to one of the world’s most powerful industries.

Pre-launch accessRegister now before the PledgeMe campaign goes live. First in, first to know when the opportunity opens.
📈
Early-stage valuationNZD $21M pre-money. The US market opportunity is USD $30B. The math is compelling at this stage.
🇩🇿
A NZ success story in the makingThis is what it looks like when New Zealanders back their own. Don’t read about it later — be part of it now.

Reserve your place

No commitment required. We’ll contact you personally when the PledgeMe campaign opens.

← Back

Thank you for your response. ✨

No spam. No commitment. Just a personal notification when the campaign opens on PledgeMe.

As featured in